Congress moves to permanently ban nitazenes, a dangerous synthetic opioid
H.R. 7970 — STOP Nitazenes Act · Filed by Robert Latta (R-OH) · 10 cosponsors · Introduced Mar 18, 2026 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill permanently adds nitazenes—a class of synthetic opioids structurally related to 2-benzylbenzimidazole—to Schedule I of the Controlled Substances Act, making them illegal to manufacture, distribute, or possess without authorization. The bill converts any nitazenes that were temporarily scheduled under emergency procedures into permanent Schedule I status and directs the Attorney General to issue implementing rules within one year, which may take effect immediately as interim rules before public comment is complete.
Why we flagged it
The bill's core function is to move a synthetic opioid from temporary to permanent Schedule I status under federal drug law, a routine public-health measure to prevent distribution of a substance linked to overdose deaths.
What the text implies
- The interim final rule provision (Section 3(b)(1)) allows the Attorney General to make rules effective immediately without demonstrating good cause, bypassing the normal notice-and-comment requirement under the Administrative Procedure Act. This accelerates implementation but reduces opportunity for public input before rules take effect.
- The structural definition of 2-benzylbenzimidazole opioids in Section 2(2) is broad and includes a catch-all provision for any substance exhibiting agonist activity at the mu-opioid receptor, potentially capturing future analogs not yet synthesized. This may preempt clandestine chemists from easily designing workarounds, but also means the DEA's interpretation of 'agonist activity' will determine
The full analysis lists 3 implications of this text.
Who it affects
Permanently scheduling nitazenes as Schedule I controlled substances removes a dangerous synthetic opioid from legal circulation, protecting public health by preventing manufacture and distribution. The bill addresses a documented public-health threat (nitazenes have been linked to overdose deaths and are increasingly diverted into illicit drug supplies) without creating new restrictions on citizens' lawful conduct or rights.